What signs indicate I need to consult with my healthcare team
Additionally, biotechnology and pharmaceutical companies are examining how to repurpose molecules implicated in skeletal muscle pathways (such as myostatin/activin, apelin, and mTOR), and developing new molecules and medications to maintain SMM while benefiting from GLP-1 medications' positive health effects
If your symptoms are mild to moderate, these strategies are often enough to help you get through it
Adults 18 and older on Medicare Part D who meet one of three BMI tiers at the time GLP-1 therapy is initiated: BMI 35, BMI 30 with a comorbidity (heart failure with preserved EF, uncontrolled hypertension despite two antihypertensives, or chronic kidney disease stage 3a+), or BMI 27 with a cardiovascular comorbidity (pre-diabetes by ADA criteria, prior heart attack, prior stroke, or symptomatic peripheral artery disease)
The solution should remain clear